Aimee L. Kenoyer

1.1k total citations
35 papers, 827 citations indexed

About

Aimee L. Kenoyer is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Aimee L. Kenoyer has authored 35 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Aimee L. Kenoyer's work include Radiopharmaceutical Chemistry and Applications (22 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Lymphoma Diagnosis and Treatment (8 papers). Aimee L. Kenoyer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Lymphoma Diagnosis and Treatment (8 papers). Aimee L. Kenoyer collaborates with scholars based in United States, South Africa and Sweden. Aimee L. Kenoyer's co-authors include Barbara E. Menzies, D. Scott Wilbur, Oliver W. Press, Donald K. Hamlin, Damian J. Green, Darrell R. Fisher, John M. Pagel, Ajay K. Gopal, Johnnie J. Orozco and Yukang Lin and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Aimee L. Kenoyer

34 papers receiving 815 citations

Peers

Countries citing papers authored by Aimee L. Kenoyer

Since Specialization

Citations

This map shows the geographic impact of Aimee L. Kenoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimee L. Kenoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimee L. Kenoyer more than expected).

Fields of papers citing papers by Aimee L. Kenoyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimee L. Kenoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimee L. Kenoyer. The network helps show where Aimee L. Kenoyer may publish in the future.

Co-authorship network of co-authors of Aimee L. Kenoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Aimee L. Kenoyer. A scholar is included among the top collaborators of Aimee L. Kenoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimee L. Kenoyer. Aimee L. Kenoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	²¹¹At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation 2024 ·Journal of Nuclear Medicine ·Sofia H.L. Frost, Johnnie J. Orozco, Tom Bäck, Brian W. Miller, Erlinda B. Santos, Aimee L. Kenoyer, Sue E. Knoblaugh, Donald K. Hamlin, D. Scott Wilbur, Brenda M. Sandmaier	0
2	Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma 2023 ·EJNMMI Research ·Kevin P. Labadie, (unknown), Aimee L. Kenoyer, Donald K. Hamlin, Andrew D. Ludwig, Alan F. Utria, Sara K. Daniel, (unknown), (unknown), Johnnie J. Orozco, Yawen Li, D. Scott Wilbur, Robert S. Miyaoka, James O. Park	3
3	Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system 2022 ·Scientific Reports ·(unknown), Brenda M. Sandmaier, (unknown), Sofia H.L. Frost, Erlinda B. Santos, Aimee L. Kenoyer, Donald K. Hamlin, D. Scott Wilbur, Robert D. Stewart, Darrell R. Fisher, K. Vetter, Youngho Seo, Brian W. Miller	19
4	Glypican-3–Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma 2021 ·Journal of Nuclear Medicine ·Kevin P. Labadie, Donald K. Hamlin, Aimee L. Kenoyer, Sara K. Daniel, Alan F. Utria, Andrew D. Ludwig, Heidi L. Kenerson, (unknown), Jonathan G. Sham, Delphine L. Chen, Johnnie J. Orozco, Raymond S. Yeung, Chris Orvig, Yawen Li, D. Scott Wilbur, James O. Park	20
5	Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma 2021 ·Scientific Reports ·Kevin P. Labadie, Andrew D. Ludwig, (unknown), Donald K. Hamlin, Aimee L. Kenoyer, Kevin M. Sullivan, Sara K. Daniel, (unknown), Jonathan G. Sham, Johnnie J. Orozco, Raymond S. Yeung, Delphine L. Chen, D. Scott Wilbur, Robert S. Miyaoka, James O. Park	14
6	Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA 2020 ·Molecular Cancer Therapeutics ·Johnnie J. Orozco, Aimee L. Kenoyer, Yukang Lin, Shyril O’Steen, (unknown), (unknown), (unknown), Mark D. Hylarides, Darrell R. Fisher, (unknown), Donald K. Hamlin, D. Scott Wilbur, Kelly Davis Orcutt, K. Dane Wittrup, Damian J. Green, Ajay K. Gopal, Brian G. Till, Brenda M. Sandmaier, Oliver W. Press, John M. Pagel	8
7	The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model 2019 ·Blood ·Shyril O’Steen, Melissa L. Comstock, Johnnie J. Orozco, Donald K. Hamlin, D. Scott Wilbur, Jon C. Jones, Aimee L. Kenoyer, (unknown), Yukang Lin, Brian W. Miller, Theodore A. Gooley, Sherilyn A. Tuazon, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, Oliver W. Press, Damian J. Green	46
8	cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies 2018 ·PLoS ONE ·Yawen Li, Donald K. Hamlin, Ming‐Kuan Chyan, Roger Wong, (unknown), (unknown), (unknown), Ronald Manger, (unknown), Aimee L. Kenoyer, Johnnie J. Orozco, Damian J. Green, Oliver W. Press, Rainer Storb, Brenda M. Sandmaier, D. Scott Wilbur	28
9	Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas 2017 ·Cancer Research ·Shyril O’Steen, Damian J. Green, Ajay K. Gopal, Johnnie J. Orozco, Aimee L. Kenoyer, Yukang Lin, D. Scott Wilbur, Donald K. Hamlin, Darrell R. Fisher, Mark D. Hylarides, Theodore A. Gooley, (unknown), Brian G. Till, Oliver W. Press	23
10	CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies 2017 ·Blood ·Damian J. Green, Shyril O’Steen, Yukang Lin, Melissa L. Comstock, Aimee L. Kenoyer, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, (unknown), Mark D. Hylarides, Ajay K. Gopal, Theodore A. Gooley, Johnnie J. Orozco, Brian G. Till, Kelly Davis Orcutt, K. Dane Wittrup, Oliver W. Press	40
11	Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers 2016 ·Cancer Research ·Damian J. Green, Shani L. Frayo, Yukang Lin, Donald K. Hamlin, Darrell R. Fisher, Sofia H.L. Frost, Aimee L. Kenoyer, Mark D. Hylarides, Ajay K. Gopal, Theodore A. Gooley, Johnnie J. Orozco, Brian G. Till, Shyril O’Steen, Kelly Davis Orcutt, D. Scott Wilbur, K. Dane Wittrup, Oliver W. Press	22
12	Quantitative single‐particle digital autoradiography with α‐particle emitters for targeted radionuclide therapy using the iQID camera 2015 ·Medical Physics ·Brian W. Miller, Sofia H.L. Frost, Shani L. Frayo, Aimee L. Kenoyer, Erlinda B. Santos, Jon C. Jones, Damian J. Green, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Johnnie J. Orozco, Oliver W. Press, John M. Pagel, Brenda M. Sandmaier	56
13	α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After ²¹¹At-Radioimmunotherapy for Hematopoietic Cell Transplantation 2015 ·Journal of Nuclear Medicine ·Sofia H.L. Frost, Brian W. Miller, Tom Bäck, Erlinda B. Santos, Donald K. Hamlin, Sue E. Knoblaugh, Shani L. Frayo, Aimee L. Kenoyer, Rainer Storb, Oliver W. Press, D. Scott Wilbur, John M. Pagel, Brenda M. Sandmaier	22
14	In Vivo Localization of 90Y and 177Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model 2014 ·Cancer Research ·(unknown), Aimee L. Kenoyer, Johnnie J. Orozco, (unknown), Mazyar Shadman, Darrell R. Fisher, Damian J. Green, Mark D. Hylarides, Oliver W. Press, D. Scott Wilbur, John M. Pagel	19
15	Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model 2014 ·PLoS ONE ·Johnnie J. Orozco, (unknown), Ted Gooley, Aimee L. Kenoyer, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Mark D. Hylarides, Mazyar Shadman, Damian J. Green, Ajay K. Gopal, Oliver W. Press, John M. Pagel	8
16	A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies 2013 ·Cancer Research ·Damian J. Green, Nural Orgun, Jon C. Jones, Mark D. Hylarides, John M. Pagel, Donald K. Hamlin, D. Scott Wilbur, Yukang Lin, Darrell R. Fisher, Aimee L. Kenoyer, Shani L. Frayo, Ajay K. Gopal, Johnnie J. Orozco, Theodore A. Gooley, Brent L. Wood, William Bensinger, Oliver W. Press	40
17	Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model 2013 ·Blood ·Johnnie J. Orozco, Tom Bäck, Aimee L. Kenoyer, (unknown), Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, Shani L. Frayo, Mark D. Hylarides, Damian J. Green, Ajay K. Gopal, Oliver W. Press, John M. Pagel	54
18	Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma 2011 ·Clinical Cancer Research ·Steven Park, (unknown), (unknown), Donald K. Hamlin, Yukang Lin, D. Scott Wilbur, Patrick S. Stayton, Nural Orgun, Mark D. Hylarides, Franz Buchegger, Aimee L. Kenoyer, (unknown), Ajay K. Gopal, Damian J. Green, John M. Pagel, Oliver W. Press	27
19	Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211 2009 ·Cancer Research ·Hirohisa Nakamae, D. Scott Wilbur, Donald K. Hamlin, Monica S. Thakar, Erlinda B. Santos, Darrell R. Fisher, Aimee L. Kenoyer, John M. Pagel, Oliver W. Press, Rainer Storb, Brenda M. Sandmaier	43
20	Signal Transduction and Nuclear Responses in Staphylococcus aureus- Induced Expression of Human β-Defensin 3 in Skin Keratinocytes 2006 ·Infection and Immunity ·Barbara E. Menzies, Aimee L. Kenoyer	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact